Federal grants to Molecular Theranostics LLC
Molecular Theranostics LLC in Cleveland, Ohio received $2.6 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Cancer Detection and Diagnosis Research, with $2.0 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.6 million
- Awards3
- Awarded in FY 2025$0
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | -$594 |
| FY 2022 | 1 | $1.0 million |
| FY 2023 | 2 | $1.3 million |
| FY 2024 | 1 | $294,505 |
| FY 2025 | 0 | $0 |
Programs that fund Molecular Theranostics LLC
| Program | Awards | Amount |
|---|---|---|
| Cancer Detection and Diagnosis Research | 1 | $2.0 million |
| Oral Diseases and Disorders Research | 1 | $294,505 |
| Cancer Treatment Research | 1 | $265,179 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $2.6 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Commercialization of an mri contrast agent for differential diagnosis of prostate cancer - abstract prostate cancer is a highly heterogeneous disease and the second most cause of cancer death of men in the USA. Current methods to assess prostate cancer risk combine prostate specific antigen (PSA) sc | Cancer Detection and Diagnosis Research | September 14, 2022 | $2.0 million |
| A peptide targeted fluorescence probe for precision surgery of head and neck cancer - abstract: the goal of this sbir project is to develop and commercialize a targeted fluorescence dye for intraoperative fluorescence imaging and precision surgical treatment of head and neck cancer (HNC). Surgical r | Oral Diseases and Disorders Research | July 17, 2024 | $294,505 |
| Development of peptide drug conjugates for cancer therapy - abstract the ultimate goal of this project is to develop and commercialize peptide drug conjugates to treat life- threatening triple negative breast cancer. Triple negative breast cancer (TNBC) is a high aggressive subtype of breast cancer | Cancer Treatment Research | July 26, 2023 | $265,179 |
Questions people ask
How much federal grant money does Molecular Theranostics LLC get?
$2.6 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Molecular Theranostics LLC the most?
The Department of Health and Human Services, with $2.6 million in 3 awards.
What is Molecular Theranostics LLC's largest federal grant?
$2.0 million under Cancer Detection and Diagnosis Research, with its first action in the period on September 14, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Molecular Theranostics LLC?
Its largest are Cancer Detection and Diagnosis Research, Oral Diseases and Disorders Research and Cancer Treatment Research.
Other grant recipients in Cleveland
- Case Western Reserve University
- Greater Cleveland Regional Transit Authority
- Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
- Cuyahoga Metropolitan Housing Authority
- City of Cleveland
- Growth Opportunity Partners, Inc
- Emerald Development & Economic Network Inc
- Cuyahoga County
Largest federal grant recipients in Ohio · Federal grants in Ohio